questionsmedicales.fr
Personnes
Visiteurs des patients
Visiteurs des patients : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Visiteurs des patients : Questions médicales les plus fréquentes",
"headline": "Visiteurs des patients : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Visiteurs des patients : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-31",
"dateModified": "2025-03-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Visiteurs des patients"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Personnes",
"url": "https://questionsmedicales.fr/mesh/D009272",
"about": {
"@type": "MedicalCondition",
"name": "Personnes",
"code": {
"@type": "MedicalCode",
"code": "D009272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "M01"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Visiteurs des patients",
"alternateName": "Visitors to Patients",
"code": {
"@type": "MedicalCode",
"code": "D014789",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Samantha J Chiew",
"url": "https://questionsmedicales.fr/author/Samantha%20J%20Chiew",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Paul H Hemsworth",
"url": "https://questionsmedicales.fr/author/Paul%20H%20Hemsworth",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Sally L Sherwen",
"url": "https://questionsmedicales.fr/author/Sally%20L%20Sherwen",
"affiliation": {
"@type": "Organization",
"name": "Department of Wildlife Conservation and Science, Zoos Victoria, Parkville, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Grahame J Coleman",
"url": "https://questionsmedicales.fr/author/Grahame%20J%20Coleman",
"affiliation": {
"@type": "Organization",
"name": "Animal Welfare Science Centre, Faculty of Veterinary and Agricultural Sciences, The University of Melbourne, North Melbourne, VIC, Australia."
}
},
{
"@type": "Person",
"name": "Vicky Melfi",
"url": "https://questionsmedicales.fr/author/Vicky%20Melfi",
"affiliation": {
"@type": "Organization",
"name": "Hartpury University and Hartpury College, Gloucester, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Ionizable Lipid Nanoparticles for",
"datePublished": "2023-02-15",
"url": "https://questionsmedicales.fr/article/36789893",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/jacs.2c12893"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exosomal lipids from membrane organization to biomarkers: Focus on an endolysosomal-specific lipid.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36184001",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biochi.2022.09.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake.",
"datePublished": "2022-07-16",
"url": "https://questionsmedicales.fr/article/35850184",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Crystal Structure of the ORP8 Lipid Transport ORD Domain: Model of Lipid Transport.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37566053",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/cells12151974"
}
},
{
"@type": "ScholarlyArticle",
"name": "The signalling lipid PI3,5P",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37751887",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsob.230125"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Personnes",
"item": "https://questionsmedicales.fr/mesh/D009272"
},
{
"@type": "ListItem",
"position": 3,
"name": "Visiteurs des patients",
"item": "https://questionsmedicales.fr/mesh/D014789"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Visiteurs des patients - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Visiteurs des patients",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Visiteurs des patients",
"description": "Comment évaluer l'impact des visites sur le patient ?\nQuels signes indiquent qu'un patient a besoin de visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Visiteurs des patients",
"description": "Quels symptômes peuvent s'aggraver sans visites ?\nLes visites peuvent-elles réduire la douleur perçue ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Visiteurs des patients",
"description": "Comment prévenir l'isolement des patients ?\nQuelles mesures prendre pour des visites sûres ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Visiteurs des patients",
"description": "Les visites font-elles partie du traitement ?\nComment les hôpitaux gèrent-ils les visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Visiteurs des patients",
"description": "Quelles complications peuvent survenir sans visites ?\nLes visites peuvent-elles causer du stress au patient ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Visiteurs des patients",
"description": "Quels facteurs augmentent le besoin de visites ?\nLes patients en soins intensifs ont-ils plus besoin de visites ?",
"url": "https://questionsmedicales.fr/mesh/D014789?mesh_terms=Lipids&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact des visites sur le patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact peut être évalué par des questionnaires sur le bien-être et l'état émotionnel."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent qu'un patient a besoin de visites ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un patient peut montrer des signes de solitude, d'anxiété ou de dépression."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent s'aggraver sans visites ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'isolement social peut aggraver l'anxiété et la dépression chez le patient."
}
},
{
"@type": "Question",
"name": "Les visites peuvent-elles réduire la douleur perçue ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le soutien émotionnel des visiteurs peut diminuer la perception de la douleur."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'isolement des patients ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Encourager les visites régulières et utiliser des technologies de communication."
}
},
{
"@type": "Question",
"name": "Quelles mesures prendre pour des visites sûres ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les protocoles d'hygiène et les restrictions de visite en place."
}
},
{
"@type": "Question",
"name": "Les visites font-elles partie du traitement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les visites peuvent être considérées comme un complément au traitement médical."
}
},
{
"@type": "Question",
"name": "Comment les hôpitaux gèrent-ils les visites ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les hôpitaux établissent des horaires et des règles pour assurer la sécurité des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans visites ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de visites peut entraîner une détérioration de la santé mentale et physique."
}
},
{
"@type": "Question",
"name": "Les visites peuvent-elles causer du stress au patient ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites non planifiées ou trop fréquentes peuvent causer du stress."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin de visites ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies chroniques et l'isolement social augmentent ce besoin."
}
},
{
"@type": "Question",
"name": "Les patients en soins intensifs ont-ils plus besoin de visites ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients en soins intensifs peuvent bénéficier davantage du soutien des visiteurs."
}
}
]
}
]
}
Ionizable lipid nanoparticles (LNPs) are the most clinically advanced nonviral platform for mRNA delivery. While they have been explored for applications including vaccines and gene editing, LNPs have...
The term extracellular vesicles (EVs) has been recommended to describe various membrane-bound vesicles secreted by most living cells and found in various biological fluids. They gained growing interes...
In this study PEG-free and zeta potential changing lipid-based nanocarriers providing enhanced cellular uptake were developed. Nanostructured lipid carriers (NLC), consisting of paraffin wax, caprylic...
ORPs are lipid-transport proteins belonging to the oxysterol-binding protein family. They facilitate the transfer of lipids between different intracellular membranes, such as the ER and plasma membran...
Coordination of mitotic exit with chromosome segregation is key for successful mitosis. Mitotic exit in budding yeast is executed by the mitotic exit network (MEN), which is negatively regulated by th...
Lipids are undoubtedly the major constituents of the cell membranes of all living organisms, and the most efficient source of energy [...]....
The characterization of lipid binding to lipid transfer proteins (LTPs) is fundamental to understand their molecular mechanism. However, several structures of LTPs, and notably those proposed to act a...
Peptide-lipid hybrid vesicles were prepared with complementary DNA strands in their lipid domains. Hybridization of the complementary DNA strands induced the controlled fusion of the vesicles during r...
Lipid nanoparticles (LNPs) have emerged as promising platforms for efficient in vivo mRNA delivery owing to advancements in ionizable lipids. However, maintaining the thermostability of mRNA/LNP syste...
Since lipid nanoparticles (LNP) have emerged as a potent drug delivery system, the objective of this study was to develop and optimize a robust high-performance liquid chromatography with charged aero...